Intermediate Outcomes of HFrEF Patients on Guideline-Directed Medical Therapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This prospective observational study aims to evaluate intermediate clinical, renal, and functional outcomes in patients with heart failure with reduced ejection fraction treated with contemporary guideline-directed medical therapy over a 6 to 12 month follow-up period.
Epistemonikos ID: fdf5f520568fb67a7e51898653593324644531d4
First added on: Sep 29, 2026